131 related articles for article (PubMed ID: 7509244)
1. Role of neutral endopeptidase and kininase II on substance P-induced increase in nasal obstruction in patients with allergic rhinitis.
Lurie A; Nadel JA; Roisman G; Siney H; Dusser DJ
Am J Respir Crit Care Med; 1994 Jan; 149(1):113-7. PubMed ID: 7509244
[TBL] [Abstract][Full Text] [Related]
2. Effects of aerosolised substance P on lung resistance in guinea-pigs: a comparison between inhibition of neutral endopeptidase and angiotensin-converting enzyme.
Lötvall JO; Skoogh BE; Barnes PJ; Chung KF
Br J Pharmacol; 1990 May; 100(1):69-72. PubMed ID: 1695534
[TBL] [Abstract][Full Text] [Related]
3. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis.
Braunstein G; Fajac I; Lacronique J; Frossard N
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):630-5. PubMed ID: 1716429
[TBL] [Abstract][Full Text] [Related]
4. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo.
Cheung D; Bel EH; Den Hartigh J; Dijkman JH; Sterk PJ
Am Rev Respir Dis; 1992 Jun; 145(6):1275-80. PubMed ID: 1317691
[TBL] [Abstract][Full Text] [Related]
5. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis.
Devillier P; Dessanges JF; Rakotosihanaka F; Ghaem A; Boushey HA; Lockhart A; Marsac J
Eur Respir J; 1988 Apr; 1(4):356-61. PubMed ID: 2456227
[TBL] [Abstract][Full Text] [Related]
6. Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.
Nichol GM; O'Connor BJ; Lecomte JM; Chung KF; Barnes PJ
Eur J Clin Pharmacol; 1992; 42(5):491-4. PubMed ID: 1376694
[TBL] [Abstract][Full Text] [Related]
7. Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Valero A; Serrano C; Bartrá J; Izquierdo I; Muñoz-Cano R; Mullol J; Picado C
J Investig Allergol Clin Immunol; 2009; 19(6):488-93. PubMed ID: 20128424
[TBL] [Abstract][Full Text] [Related]
8. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase inhibitor thiorphan increases airway narrowing to inhaled sodium metabisulfite in normal subjects.
Bellofiore S; Caltagirone F; Pennisi A; Ciancio N; Mistretta A; Di Maria GU
Am J Respir Crit Care Med; 1994 Sep; 150(3):853-6. PubMed ID: 8087360
[TBL] [Abstract][Full Text] [Related]
10. Nasal response to capsaicin in patients with allergic rhinitis and in healthy volunteers: effect of colchicine.
Roche N; Lurie A; Authier S; Dusser DJ
Am J Respir Crit Care Med; 1995 Apr; 151(4):1151-8. PubMed ID: 7697245
[TBL] [Abstract][Full Text] [Related]
11. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis.
Aubier M; Levy J; Clerici C; Neukirch F; Herman D
Am Rev Respir Dis; 1992 Jul; 146(1):122-6. PubMed ID: 1626795
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo.
Cheung D; Timmers MC; Zwinderman AH; den Hartigh J; Dijkman JH; Sterk PJ
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1467-73. PubMed ID: 8256886
[TBL] [Abstract][Full Text] [Related]
14. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
15. Decongestion test in patients with allergic rhinitis: functional evaluation of nasal airflow.
Ciprandi G; Cirillo I; Vizzaccaro A; Pallestrini E; Tosca MA
Am J Rhinol; 2006; 20(2):224-6. PubMed ID: 16686394
[TBL] [Abstract][Full Text] [Related]
16. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis.
Maniscalco M; Sofia M; Carratù L; Higenbottam T
Eur J Clin Invest; 2001 May; 31(5):462-6. PubMed ID: 11380599
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Tinospora cordifolia in allergic rhinitis.
Badar VA; Thawani VR; Wakode PT; Shrivastava MP; Gharpure KJ; Hingorani LL; Khiyani RM
J Ethnopharmacol; 2005 Jan; 96(3):445-9. PubMed ID: 15619563
[TBL] [Abstract][Full Text] [Related]
18. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
Webb DR; Meltzer EO; Finn AF; Rickard KA; Pepsin PJ; Westlund R; Cook CK
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic blockade does not alter the nasal congestive response to irritant provocation.
Shusterman D; Murphy MA; Walsh P; Balmes JR
Rhinology; 2002 Sep; 40(3):141-6. PubMed ID: 12357714
[TBL] [Abstract][Full Text] [Related]
20. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
